Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

NCT01692301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

454

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: LCZ696
DRUG: Olmesartan
DRUG: LCZ696 matching placebo
DRUG: Olmesartan matching placebo
DRUG: amlodipine
DRUG: hydrochlorothiazide

Sponsor

Novartis Pharmaceuticals